Yet, under NASH-fed conditions, CD53 KO eWAT exhibited reduced c-type lectin receptor signaling, B-cell receptor signaling, platelet activation, and complement/coagulation cascades, and upregulated cholesterol metabolism pathways (Figs. 5C and S2). This evidence concerns the gene CD53 and metabolic dysfunction-associated steatohepatitis.